(Q34580194)

3 August 2017

title

Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics (English)

1 reference

3 August 2017

main subject

antimicrobial resistance

1 reference

Carl T Bergstrom

3

0 references

author name string

Mark M Tanaka

series ordinal

1

1 reference

3 August 2017

Benjamin M Althouse

series ordinal

2

1 reference

3 August 2017

publication date

5 November 2014

1 reference

Evolution, medicine, and public health

3 August 2017

published in

1 reference

3 August 2017

volume

2014

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

150-161

1 reference

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

The timing and targeting of treatment in influenza pandemics influences the emergence of resistance in structured populations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Mitigation strategies for pandemic influenza A: balancing conflicting policy objectives

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains on competitive exclusion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Evolution in health and medicine Sackler colloquium: a public choice framework for controlling transmissible and evolving diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Population-wide emergence of antiviral resistance during pandemic influenza

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Modeling targeted layered containment of an influenza pandemic in the United States.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Time lines of infection and disease in human influenza: a review of volunteer challenge studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Antiviral treatment for the control of pandemic influenza: some logistical constraints

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Seasonal influenza in the United States, France, and Australia: transmission and prospects for control

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

John F. Enders lecture 2006: antivirals for influenza

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Antiviral resistance and the control of pandemic influenza

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Mutations of Bacteria from Virus Sensitivity to Virus Resistance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Upgrading antibiotic use within a class: tradeoff between resistance and treatment success

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Emergence of drug-resistant influenza virus: population dynamical considerations.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Strategies for containing an emerging influenza pandemic in Southeast Asia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Containing pandemic influenza at the source.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Transmissibility of 1918 pandemic influenza

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Early administration of oral oseltamivir increases the benefits of influenza treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Antimicrobial use and antimicrobial resistance: a population perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Preliminary analysis of the transmission dynamics of nosocomial infections: stochastic and management effects.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Emergence of drug resistance during an influenza epidemic: insights from a mathematical model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Evaluating treatment protocols to prevent antibiotic resistance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability model

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FEMPH%2FEOU027

Emergence of drug resistance: implications for antiviral control of pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEMPH%2FEOU027

Optimal antiviral treatment strategies and the effects of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEMPH%2FEOU027

What is the best control strategy for multiple infectious disease outbreaks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEMPH%2FEOU027

A Contribution to the Mathematical Theory of Epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEMPH%2FEOU027

Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEMPH%2FEOU027

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEMPH%2FEOU027

Modeling the spread of resistant nosocomial pathogens in an intensive-care unit

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246056

27 October 2018

Identifiers

DOI

10.1093/EMPH/EOU027

1 reference

3 August 2017

1 reference

3 August 2017

1 reference